1. Low rotational barriers for the most dynamically active methyl groups in the proposed antiviral drugs for treatment of SARS-CoV-2, apilimod and tetrandrine
- Author
-
Yongqiang Cheng, Luke L. Daemen, Matthew R. Ryder, Eugene Mamontov, Anibal J. Ramirez-Cuesta, Alexander I. Kolesnikov, and Matthew B. Stone
- Subjects
2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,medicine.drug_class ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,General Physics and Astronomy ,02 engineering and technology ,Pharmacology ,DFT calculations ,inelastic neutron scattering ,01 natural sciences ,chemistry.chemical_compound ,microscopic dynamics ,0103 physical sciences ,medicine ,Physical and Theoretical Chemistry ,Molecular drugs ,Screening study ,010304 chemical physics ,Chemistry ,quasielastic neutron scattering ,021001 nanoscience & nanotechnology ,Tetrandrine ,Antiviral drug ,0210 nano-technology ,Rotational dynamics ,Research Paper - Abstract
A recent screening study highlighted a molecular compound, apilimod, for its efficacy against the SARS-CoV-2 virus, while another compound, tetrandrine, demonstrated a remarkable synergy with the benchmark antiviral drug, remdesivir. Here, we find that because of significantly reduced potential energy barriers, which also give rise to pronounced quantum effects, the rotational dynamics of the most dynamically active methyl groups in apilimod and tetrandrine are much faster than those in remdesivir. Because dynamics of methyl groups are essential for biochemical activity, screening studies based on the computed potential energy profiles may help identify promising candidates within a given class of drugs.
- Published
- 2021